| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cancer Prevention Research Program [C. A., H. E. S., J. W. L.] and Program in Epidemiology [E. D. F., C. C., S. M. S.], Fred Hutchinson Cancer Research Center, Seattle, Washington 98109; Center for Health Studies, Group Health Cooperative of Puget Sound, Seattle, Washington 98101 [D. S.]; University of Helsinki, Helsinki, Finland [K. W.]; and Department of Epidemiology, University of Washington, Seattle, Washington 98195 [D. S., S. M. S.]
Dietary isoflavones are biologically active in humans, but few observational data exist on the relationship between isoflavone intake and excretion in Western populations. We examined associations between self-reported soy intakes and overnight urinary isoflavone excretion in a population-based sample of western Washington State women, and we investigated the usefulness of one versus two overnight urine samples, collected 48 h apart, as a biomarker of intake. Isoflavones (genistein, daidzein, O-desmethylangolensin, and equol) were measured in two overnight urine collections from 363 women recruited from a health maintenance organization. Soy food intakes were assessed using two 1-day diet records completed on each day prior to the urine collections and a food frequency questionnaire (FFQ) that had been completed by 312 of the women with regard to their dietary habits 3.5 years (range, 25 years) before the urine collections. Twenty-one percent of the women consumed soy on either day of the diet recall, and 13% and 34% of the women consumed soy at least once a week or at least once a month, respectively, according to the FFQ. Women who consumed soy at either of the two diet recalls or at the FFQ (at least once a week or at least once a month) had a significantly higher urinary excretion of isoflavones than women who did not consume soy (P < 0.01). Among women who consumed soy at either of the two diet recalls or at the FFQ (soy consumed at least once a month), isoflavone intake and excretion correlated significantly (P < 0.01). Excretion of the individual isoflavones correlated significantly between the two urine samples collected 48 h apart (genistein, r = 0.41 and P < 0.001; daidzein, r = 0.30 and P < 0.001; O-desmethylangolensin, r = 0.46 and P < 0.001; equol, r = 0.60 and P < 0.001). Differences between soy consumers and nonconsumers and associations between intakes and excretion remained significant whether one or both urine collections were considered. Measuring isoflavone excretion in one overnight urine collection serves as a biomarker of recent or past isoflavone intake, even in populations whose intake of soy foods is relatively low.
This article has been cited by other articles:
![]() |
K. Jaceldo-Siegl, G. E Fraser, J. Chan, A. Franke, and J. Sabate Validation of soy protein estimates from a food-frequency questionnaire with repeated 24-h recalls and isoflavonoid excretion in overnight urine in a Western population with a wide range of soy intakes Am. J. Clinical Nutrition, May 1, 2008; 87(5): 1422 - 1427. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R Walsh, S. J Haak, T. Bohn, Q. Tian, S. J Schwartz, and M. L Failla Isoflavonoid glucosides are deconjugated and absorbed in the small intestine of human subjects with ileostomies Am. J. Clinical Nutrition, April 1, 2007; 85(4): 1050 - 1056. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Atkinson, J. W Lampe, D. Scholes, C. Chen, K. Wahala, and S. M Schwartz Lignan and isoflavone excretion in relation to uterine fibroids: a case-control study of young to middle-aged women in the United States. Am. J. Clinical Nutrition, September 1, 2006; 84(3): 587 - 593. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A Franke, B. M Halm, L. J Custer, Y. Tatsumura, and S. Hebshi Isoflavones in breastfed infants after mothers consume soy. Am. J. Clinical Nutrition, August 1, 2006; 84(2): 406 - 413. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Atkinson, C. L. Frankenfeld, and J. W. Lampe Gut Bacterial Metabolism of the Soy Isoflavone Daidzein: Exploring the Relevance to Human Health Experimental Biology and Medicine, March 1, 2005; 230(3): 155 - 170. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Manach, A. Scalbert, C. Morand, C. Remesy, and L. Jimenez Polyphenols: food sources and bioavailability Am. J. Clinical Nutrition, May 1, 2004; 79(5): 727 - 747. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. B. Grace, J. I. Taylor, Y.-L. Low, R. N. Luben, A. A. Mulligan, N. P. Botting, M. Dowsett, A. A. Welch, K.-T. Khaw, N. J. Wareham, et al. Phytoestrogen Concentrations in Serum and Spot Urine as Biomarkers for Dietary Phytoestrogen Intake and Their Relation to Breast Cancer Risk in European Prospective Investigation of Cancer and Nutrition-Norfolk Cancer Epidemiol. Biomarkers Prev., May 1, 2004; 13(5): 698 - 708. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Atkinson, S. Berman, O. Humbert, and J. W. Lampe In Vitro Incubation of Human Feces with Daidzein and Antibiotics Suggests Interindividual Differences in the Bacteria Responsible for Equol Production J. Nutr., March 1, 2004; 134(3): 596 - 599. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Cell Growth & Differentiation |